A PYMNTS Company

US: Quintiles, IMS Health plan $9billion merger

By  |  May 4, 2016

IMS Health Holdings plans to merge with Quintiles Transnational Holdings, the companies said today, in an approximately $9 billion deal designed to create one of the world’s largest providers of healthcare data, technology, and services solutions.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The merger will create a combined entity—to be called Quintiles IMS Holdings—with combined 2015 revenue of $7.2 billion and combined market capitalization of more than $17.6 billion.

    IMS Health shareholders will receive 0.384 shares of Quintiles common stock for each share of IMS Health common stock. Upon completion of the merger, IMS Health shareholders will own approximately 51.4% of the shares of the combined company, with the remaining 48.6% to be owned by Quintiles shareholders.

    “This combination addresses life science companies’ most pressing needs: to transform the clinical development of innovative medicines, demonstrate the value of these medicines in the real world, and drive commercial success,” Quintiles CEO Tom Pike said in a statement.

    Full Content: NY Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.